The prolongation of the EPAAC trial - NCT00152464 (the Early Prevention of Asthma in Atopic Children). A multi-country, double blind, placebo (PLC) controlled, follow-up trial with 3 parallel groups (LCTZ-LCTZ, LCTZ-PLC and PLC-PLC) : evaluation of the long term efficacy and safety of levocetirizine (LCTZ) (5 mg/mL oral drops -0.125 mg/kg b.w. b.i.d. [twice daily]) administered for an additional 18 months period in preventing the onset of asthma in children coming from the EPAAC trial.

Trial Profile

The prolongation of the EPAAC trial - NCT00152464 (the Early Prevention of Asthma in Atopic Children). A multi-country, double blind, placebo (PLC) controlled, follow-up trial with 3 parallel groups (LCTZ-LCTZ, LCTZ-PLC and PLC-PLC) : evaluation of the long term efficacy and safety of levocetirizine (LCTZ) (5 mg/mL oral drops -0.125 mg/kg b.w. b.i.d. [twice daily]) administered for an additional 18 months period in preventing the onset of asthma in children coming from the EPAAC trial.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 29 Oct 2014

At a glance

  • Drugs Levocetirizine (Primary)
  • Indications Asthma
  • Focus Registrational; Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 20 Oct 2009 Additional locations identified as reported by ClinicalTrials.gov.
    • 13 Mar 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov, last updated 13-Mar-2009.
    • 13 Mar 2009 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top